Pharmaceuticals market research reports by DelveInsight

• Potassium Channel Openers - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Potassium Channel Openers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Potassium Channel Openers development. The report provides detailed coverage of the pipeline landscape for t ... Read More

• Serotonin Transporter Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Serotonin Transporter Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Transporter Inhibitor development. The report provides detailed coverage of the pipeline lan ... Read More

• TGF-Beta Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “TGF-Beta Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TGF-Beta Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Cation Channel, Sub ... Read More

• Ocular Hypertension - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 3,000

  DelveInsight’s, “Ocular Hypertension - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Ocular Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More

• Neuroendocrine tumors - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 3,000

  DelveInsight’s, “Neuroendocrine tumors - Pipeline Insight, 2025” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Neuroendocrine tumors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More

• Dry Eye Disease - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,500

  DelveInsight’s, “Dry Eye Disease - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Dry Eye Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More

• Tie-2 Receptor Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Tie-2 Receptor Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Tie-2 Receptor Inhibitor development. The report provides detailed coverage of the pipeline landscape for thi ... Read More

• 20s Proteasome Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “20s Proteasome Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides detailed coverage of the pipeline landscape for thi ... Read More

• 30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  “30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 30S Ribosomal Subunit (30S RNA) Inhibitor development. The report provides detailed coverage ... Read More

• 5-HT1 Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “5-HT1 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More

• 5-HT1B Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “5-HT1B Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More

• Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2 Receptor Antagonist development. The report provides detailed coverage of the pipeline l ... Read More

• Alpha-1A Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Alpha-1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More

• Alpha-2 Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Alpha-2 Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-2 Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of act ... Read More

• Alpha-Amylase Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Alpha-Amylase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-Amylase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this ... Read More

• Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More

• Angiotensin Modulators - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Angiotensin Modulators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Modulators development. The report provides detailed coverage of the pipeline landscape for this me ... Read More

• Arginine Depletors - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Arginine Depletors - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Arginine Depletors development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  “Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-1 (IL-1) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More

• Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Interleukin-4 (IL-4) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-4 (IL-4) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More

• Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Interleukin-8 (IL-8) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-8 (IL-8) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More

• Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Kv1.3/1.5 Potassium Channel Blockers development. The report provides detailed coverage of the pi ... Read More

• Ebola Fever - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  DelveInsight’s, “Ebola Fever - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Ebola Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessmen ... Read More

• Inclusion Body Myositis- Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  DelveInsight’s, “Inclusion Body Myositis- Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Inclusion Body Myositis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >